Medicare Enrolled
Dr. Khashayar Vahdat, M.D.
Cardiovascular Disease · Longview, TX
Practice pattern: Cardiac & Cardiac
— Practice combining cardiac and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vahdat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vahdat?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vahdat
Dr. Khashayar Vahdat is a cardiovascular disease specialist in Longview, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Vahdat performed 2,118 Medicare services across 1,930 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vahdat received a total of $4,176 from 35 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vahdat is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 47% volume in TX
$4,176 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,118
Medicare services
Top 47% in TX for cardiovascular disease
1,930
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~163 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
378 | $50 | $687 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
374 | $6 | $19 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
111 | $16 | $49 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
111 | $10 | $33 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
107 | $56 | $265 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
106 | $135 | $441 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
99 | $62 | $159 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
82 | $2 | $49 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
79 | $20 | $68 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $44 | $204 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $97 | $375 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
49 | $19 | $340 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
48 | $26 | $140 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
47 | $14 | $177 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
43 | $10 | $173 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
42 | $83 | $831 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $97 | $300 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
35 | $5 | $88 |
| Cardiac catheterization | 35 | $218 | $3,680 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
32 | $18 | $56 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $101 | $406 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
28 | $91 | $228 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
26 | $20 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $61 | $289 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
22 | $12 | $132 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $56 | $251 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
12 | $18 | $56 |
| New patient office visit, complex (60-74 min) | 11 | $131 | $496 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.4% high complexity
23.7% medium
45.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,176
Total received (2018-2024)
Avg $597/year across 7 years
Bottom 47% in TX for cardiovascular disease
35
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,149 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$250
2023
$548
2022
$568
2021
$276
2020
$171
2019
$1,018
2018
$1,346
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$646
Novartis Pharmaceuticals Corporation
$481
E.R. Squibb & Sons, L.L.C.
$360
Janssen Pharmaceuticals, Inc
$262
Amgen Inc.
$204
BIOTRONIK INC.
$155
HEARTFLOW, INC.
$149
W. L. Gore & Associates, Inc.
$147
Abbott Laboratories
$145
HeartFlow, Inc.
$137
BOSTON SCIENTIFIC CORPORATION
$136
Inari Medical, Inc.
$133
Edwards Lifesciences Corporation
$123
ABIOMED
$93
Gilead Sciences, Inc.
$83
Merck Sharp & Dohme LLC
$79
CARDIVA MEDICAL, INC.
$73
Boston Scientific Corporation
$73
Regeneron Healthcare Solutions, Inc.
$72
iRhythm Technologies, Inc.
$71
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$65
Impulse Dynamics (USA) Inc.
$57
AstraZeneca Pharmaceuticals LP
$56
PFIZER INC.
$54
Medtronic, Inc.
$52
Allergan Inc.
$52
Alnylam Pharmaceuticals Inc.
$50
Amarin Pharma Inc.
$43
Cardiovascular Systems Inc.
$33
Bayer HealthCare Pharmaceuticals Inc.
$23
Merck Sharp & Dohme Corporation
$16
AltaThera Pharmaceuticals LLC
$16
SANOFI-AVENTIS U.S. LLC
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Otsuka America Pharmaceutical, Inc.
$12
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
Azure · BRILINTA · BYSTOLIC · BYVALSON · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · Claria MRI · CoreValve Evolut · Corlanor · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · EKOSONIC · ELIQUIS · ENTRESTO · EXCLUDER Conformable AAA Endoprosthesis with Active Control · Edwards SAPIEN 3 Transcatheter Heart Valve · Endurant · FARXIGA · FFRct · FLOWTRIEVER CATHETER · GENERAL EP · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL EP · GORE VIABAHN VBX Balloon Expandable Endo · HeartMate 3 Left Ventricular Dev · Impella · JARDIANCE · Kerendia · LEQVIO · LINQ II · LifeVest · MULTAQ · Micra · ONPATTRO · OPTIMIZER · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RHYTHMIA · Repatha · S · SAMSCA · Sotalol Hydrochloride · VERQUVO · Vascepa · WATCHMAN · XACT · XARELTO · XIENCE SIERRA · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $197 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
10
Per 100K population
8.0
County median income
$64,809
Nearest hospital
CHRISTUS GOOD SHEPHERD MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vahdat is a cardiac & cardiac specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vahdat experienced with echocardiogram, transthoracic?
Based on Medicare claims data, Dr. Vahdat performed 378 echocardiogram, transthoracic services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vahdat receive payments from pharmaceutical companies?
Yes. Dr. Vahdat received a total of $4,176 from 35 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vahdat's costs compare to other cardiologists in Longview?
Dr. Vahdat's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vahdat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Longview
Browse cardiologists in Longview ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology